Registry on coronary function testing in Belgium

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, multicenter registry aims to document the real-world application of coronary function tests in Belgium, focusing on bolus thermodilution measurements and invasive vasoreactivity tests. It will assess the frequency of these tests, their indications, and the prevalence of coronary microvascular dysfunction and vasospasm among patients. Data will be collected from medical files, including cardiovascular risk factors and follow-up information, with optional questionnaires on symptoms and quality of life. The study does not require specific visits, making it a practical observational approach.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient scheduled for coronary function test, comprising of intracoronary bolus thermodilution measurements of microvascular function, and/or intracoronary vasoreactivity tests with acetylcholine.
* Subject understands the study requirements and provides written informed consent.

Exclusion Criteria:

* Subject is participating in another investigational clinical trial that may cause non-compliance with the protocol or confound data interpretation.
* Subject intends to participate in another investigational clinical trial that may cause non-compliance with the protocol or confound data interpretation.
* Documented or suspected pregnancy.
* Inability to provide written informed consent.

Where it's running

• AZ Monica
  Deurne, Antwerp, Belgium Recruiting
• AZ Sint-Maarten
  Mechelen, Antwerp, Belgium Recruiting
• Jessa Hasselt
  Hasselt, Limburg, Belgium Recruiting
• OLV Aalst
  Aalst, Belgium Recruiting
• Ziekenhuis aan de Stroom (ZAS)
  Antwerp, Belgium Recruiting
• University Hospital Antwerp
  Antwerp, Belgium Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Coronary thrombus modification to reduce microvascular damage during STEMI care

  This study tests whether modifying the clot in the heart arteries during primary PCI can lessen microvascular damage and myocardial injury in STEMI patients.

  Recruiting Odense University Hospital · Odense · NCT07646977

• CS reducer device for symptomatic HFpEF with coronary microvascular dysfunction

  This study will test whether implanting a coronary sinus (CS) reducer reduces heart muscle ischemia on stress CMR in adults with HFpEF and coronary microvascular dysfunction.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07093528

• Improving coronary blood flow in women with HIV and diabetes or chronic kidney disease

  This study will test whether referring women with HIV and diabetes or chronic kidney disease to a specialist so they can be considered for SGLT2 inhibitor medicine, compared with health education alone, improves blood flow in their hearts.

  Recruiting Phase 2 Massachusetts General Hospital · Boston, Massachusetts · NCT06843902

• Measuring heart microvascular function in heart attack patients

  This study is testing how well the tiny blood vessels in the heart work in people who have had a heart attack to see how treatment affects their recovery.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT06795035

• Effects of Tirzepatide on Heart Health in Overweight Individuals

  This study tests if tirzepatide can improve heart health and reduce plaque in the arteries of overweight people with stable coronary artery disease.

  Recruiting at 2 sites Phase 4 Steno Diabetes Center Copenhagen · Copenhagen and 2 other locations · NCT06606821

• Registry of patients with angina undergoing coronary physiology testing

  This study collects information from adults with angina to see how well different tests for heart issues work and what happens to patients over time.

  Recruiting at 6 sites Institute for Cardiovascular Diseases Dedinje · Rijeka and 9 other locations · NCT06393478

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.